CMS Considering Pharmacy Counter Discounts for Part D Drugs in Future Other Pharmacy Changes Are Likely for 2019

Lignende værker

• Proposed Changes in Medicare Hospital Payments Would Affect Pharmacy and Beyond: Drug Companies Push to Rein in 340B Discount Drugs
  af: Barlas, Stephen
  Udgivet: (2013)
• ACO Final Rule Slights Pharmacy: No “Give” on Drug Pricing, Cost Shifting, and Other Concerns
  af: Barlas, Stephen
  Udgivet: (2015)
• CMS Changes for Part D Formularies Would Mean More Authority For P&T Committees
  af: Barlas, Stephen
  Udgivet: (2009)
• Medicare Part B Drug Reimbursement Program Distresses Pharmacy Players: Program Seeks to Reduce Use of Expensive Biologics
  af: Barlas, Stephen
  Udgivet: (2016)
• FDA Considers a New Paradigm For Over-the-Counter Medications: More Power—but More Burdens—for Pharmacists and Pharmacies
  af: Barlas, Stephen
  Udgivet: (2012)